Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007

Journal of Viral Hepatitis

Volumn 17, Issue 12, 2010, Pages 879-886

  Spradling, P R ^a   Richardson, J T ^b   Buchacz, K ^a   Moorman, A C ^a   Brooks, J T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CERNER CORPORATION   (United States)

Author keywords

coinfection; HBV; HIV; prevalence; testing

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CAUCASIAN; CHILD; CHRONIC HEPATITIS; DRUG ABUSE; FEMALE; HEPATITIS B; HETEROSEXUALITY; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEGRO; OUTPATIENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SEX RATIO; VIRUS TRANSMISSION;

ADULT; AMBULATORY CARE FACILITIES; CITIES; COHORT STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES; VACCINATION;

EID: 78649293226     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01249.x     Document Type: Article

References (24)

1. Konopnicki D, Mocroft A, De Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593 - 601.
2. Kellerman SE, Hanson DL, McNaughton AD, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B in human immunodeficiency virus-infected subjects. J Infect Dis 2003; 188: 571 - 577.
3. Thio CL, Seaberg EC, Skolasky Jr R, et al. Multicenter AIDS Cohort Study HIV-1, hepatitis B virus and risk of liver related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360: 1921 - 1926.
4. Ockenga J, Tillman HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27: 18 - 24.
5. Sheng W, Chen M, Hsieh S, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis 2004; 38: 1476 - 1482.
6. Bonacini M, Louie S, Bzowej N, et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18: 2039 - 2045.
7. CDC. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57 (RR-8): 1 - 20.
8. CDC. Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1985; 39 (RR-2): 1 - 26.
9. MacKellar DA, Valleroy LA, Secura GM, et al. Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health 2001; 91: 965 - 971.
10. Tedaldi EM, Baker RK, Moorman AC, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004; 38: 1478 - 1484.
11. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med 1998; 338: 853 - 860.
12. Moorman AC, Holmberg SD, Marlowe SI, et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV Outpatient Study (HOPS). Ann Epidemiol 1999; 9: 349 - 357.
13. Beck EJ, Mandalia S, Leonard K, et al. Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmission. Int J STD AIDS 1996; 7: 34 - 38.
14. Staples Jr CT, Rimland D, Dudas D,. Hepatitis C in the HIV Atlanta VA Cohort Study. Clin Infect Dis 1999; 29: 150 - 154.
15. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C infection among injection drug users. Medicine 1995; 74: 212 - 220.
16. Alter MJ,. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006; 44: S6 - S9.
17. CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR Recomm Rep 2006; 55 (No. RR-16): 1 - 33.
18. Lincoln D, Petoumenos K, Dore HI, for the Australian HIV Observational Database. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003; 4: 241 - 249.
19. Gandhi RT, Wurcel A, McGovern B, et al. Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen. J Acquir Immune Defic Syndr 2003; 34: 439 - 441. (Pubitemid 37444474)
20. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States: the national health and nutrition examination surveys, 1976 through 1994. Am J Pub Health 1999; 89: 14 - 18.
21. CDC. Hepatitis B Virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991; 40 (RR-13): 1 - 19.
22. CDC. Vaccination coverage among children in kindergarten-United States, 2006-07 school year. MMWR Recomm Rep 2007; 56: 819 - 821.
23. CDC. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 (RR-4): 1 - 207.
24. Justice A,. Prioritizing primary care in HIV: comorbidity, toxicity, and demography. Top HIV Med 2006; 14 (5): 159 - 163.